Pharmaceutical care for patients with coronary heart disease: transformation of pharmaceutical practice
DOI:
https://doi.org/10.14739/2409-2932.2024.3.306171Keywords:
pharmaceutical care, pharmaceutical service, coronary heart disease, cardiovascular diseases, pharmaceutical provision, pharmaceutical servicesAbstract
The implementation of the National Recovery Plan of Ukraine in the field of “Health Care”, namely the restoration of the pharmaceutical sector, improving the population’s access to medicines and their proper use, taking into account the regulatory and legal field harmonized with European legislation, in the context of providing the qualified pharmaceutical care and pharmaceutical services requires application of modern approaches based on evidence-based medicine and implementation in pharmaceutical practice. Patients with cardiovascular diseases, who are provided with medication under the Reimbursement Program and prescriptions from doctors, must be accompanied by pharmaceutical care based on evidence-based medicine to ensure proper use of drugs and rational pharmacotherapy.
The aim of the study was to investigate Ukrainian information and scientific databases, scientometric databases, i. e.: Embase, Web of Science, PubMed, and Cochrane Library to identify, generalize, and systematize scientific sources of medical and pharmaceutical data on providing patient-oriented pharmaceutical care to patients with coronary heart disease and predict the future vector of research on the specified topic.
Results. The analysis of the main strategies of providing pharmaceutical care to patients with cardiovascular diseases, in particular, coronary heart disease in pharmaceutical practice was carried out; the most researched clusters of providing pharmaceutical care were identified; modern trends and tendencies in the provision of pharmaceutical care to patients with coronary heart disease were summarized.
Conclusions. The development of providing qualified pharmaceutical care to patients with cardiovascular diseases is based on the principles of patient-oriented pharmacy and evidence-based medicine, which requires the design and implementation into the pharmaceutical practice of a sustainable conceptual model of providing patient-oriented pharmaceutical care by clinical pharmacists and pharmacists of pharmacy institutions with the expansion of the main roles, respectively the standards of Good Pharmacy Practice.
References
Health profile Ukraine [Internet]. World Life Expectancy. [cited 2024 Jun 1]. Available from: https://www.worldlifeexpectancy.com/country-health-profile/ukraine
Santos RD. EUROASPIRE V and uncontrolled risk factors in primary prevention: Atherosclerotic cardiovascular disease in the making. Eur J Prev Cardiol. 2021 May 8;28(4):380-382. doi: https://doi.org/10.1177/2047487320915662
Proekt Planu vidnovlennia Ukrainy [Project of the Recovery Plan of Ukraine] [Internet]. 2022 Jul [cited 2024 Jun 1]. Ukrainian. Available from: https://www.kmu.gov.ua/storage/app/sites/1/recoveryrada/ua/justice.pdf
Cabinet of Ministers of Ukraine. Deiaki pytannia realizatsii prohramy derzhavnykh harantii medychnoho obsluhovuvannia naselennia u 2023 rotsi [Some issues of implementation of the program of state guarantees of medical care for the population in 2023]. Resolution dated 2022 Dec 27 No. 1464 [Internet]. 2022 [cited 2024 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/1464-2022-п#Text
Verkhovna Rada of Ukraine. Pro likarski zasoby. [On Medicinal Products]. Law of Ukraine dated 2022 Jul 28 No. 2469-IX. [Internet]. 2022 [cited 2024 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/2469-20#Text
Ministry of Health of Ukraine Pro zatverdzhennia protokoliv farmatsevta [On approval of pharmacist protocols]. Order dated 2022 Jan 5 [Internet]. 2022 [cited 2024 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/v0007282-22#Text
Nalezhna aptechna praktyka: Standarty yakosti aptechnykh posluh (Spilna nastanova MFF/VOOZ z NAP) [Proper pharmacy practice: Standards of quality of pharmacy services (Joint guideline of the IFF/WHO with the National Health Service)]. Ukrainian. Available from: https://zakon.rada.gov.ua/rada/show/897_009#n2
Council of Europe Committee of Ministers Resolution CM/Res(2020)3 on the Implementation of Pharmaceutical Care for the Benefit of Patients and Health Services. [Internet], 2020 Mar 11. [cited 2024 May 29]. Available from: https://rm.coe.int/09000016809cdf26
Mishchenko OY, Iakovlieva LV, Ostashko VF. [The results of frequency analysis of drug prescriptions for patients with ischemic heart disease as a quality criterion for pharmacotherapy]. Clinical pharmacy. 2016;20(4):24-8. Ukrainian. Available from: https://dspace.nuph.edu.ua/bitstream/123456789/14135/1/24-28.pdf
Nemchenko AS, Nazarkina VN, Kurylenko YY. [The assessment of pharmaceutical care of patients with cardiovascular diseases by the results of frequency analysis of drug prescribing]. Social Pharmacy in Health Сare. 2018;4(3):20-6. Ukrainian. doi: https://doi.org/10.24959/sphhcj.18.120
Yatskova GY, Maksymovych NM, Zaliska ON. Directions of optimization of information providing of pharmaceutical prophylaxis care for arterial hypertension. Farmatsevtychnyi zhurnal. 2019;(1):31-42. doi: https://doi.org/10.32352/0367-3057.1.19.03
Khanyk N, Hromovyk B, Levytska O, Agh T, Wettermark B, Kardas P. The impact of the war on maintenance of long-term therapies in Ukraine. Front Pharmacol. 2022;13:1024046. doi: https://doi.org/10.3389/fphar.2022.1024046
Tkachenko N, Pankevych O, Mahanova T, Hromovyk B, Lesyk R, Lesyk L. Human Healthcare and Its Pharmacy Component from a Safety Point of View. Pharmacy (Basel). 2024;12(2):64. doi: https://doi.org/10.3390/pharmacy12020064
Santschi V, Chiolero A, Paradis G, Colosimo AL, Burnand B. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care. 2012;35(12):2706-17. doi: https://doi.org/10.2337/dc12-0369
Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016;133(21):2076-85. doi: https://doi.org/10.1161/CIRCULATIONAHA.115.008722
Mitkova Z, Vasileva M, Savova A, Manova M, Terezova S, Petrova G. Comparison of Cardiovascular Medicines Prices in Four European Countries. Front Public Health. 2020;8:433. doi: https://doi.org/10.3389/fpubh.2020.00433
Östbring MJ, Eriksson T, Petersson G, Hellström L. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial. BMC Cardiovasc Disord. 2021;21(1):367. doi: https://doi.org/10.1186/s12872-021-02178-0
Dixon DL, Johnston K, Patterson J, Marra CA, Tsuyuki RT. Cost-Effectiveness of Pharmacist Prescribing for Managing Hypertension in the United States. JAMA Netw Open. 2023;6(11):e2341408. doi: https://doi.org/10.1001/jamanetworkopen.2023.41408
World Health Assembly, 66. Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Geneva: World Health Organization; 2013. Available from: https://iris.who.int/handle/10665/150161
Cardiovascular diseases: A handbook for pharmacists. The Hague: International Pharmaceutical Federation; 2022.
FIP knowledge and skills reference guide for professional development in cardiovascular diseases: A companion to the FIP cardiovascular diseases handbook for pharmacists. The Hague: International Pharmaceutical Federation; 2022.
Clinical Guidelines. Cardiovascular Conditions [Internet]. [cited 2024 May 29]. American Pharmacists Association. Available from: https://www.pharmacist.com/clinical-guidelines
Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):e9-e119. doi: https://doi.org/10.1161/CIR.0000000000001168
Bilousova NA, Kabachna AV. Mental health: current trends in pharmacy and new concepts. Current issues in pharmacy and medicine: science and practice. 202;16(3):284-90. Ukrainian. doi: https://doi.org/10.14739/2409-2932.2023.3.285412
Cabinet of Ministers of Ukraine. Pro zatverdzhennia Derzhavnoi prohramy zapobihannia ta likuvannia sertsevo-sudynnykh i sudynno-mozkovykh zakhvoriuvan na 2006-2010 roky [On the approval of the Concept of the State Program for the Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases for 2006-2010]. Resolution dated 2006 May 31 No. 761 [Internet]. 2006 [cited 2024 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/761-2006-п#Text
Cabinet of Ministers of Ukraine. Pro zatverdzhennia Natsionalnoho planu zakhodiv shchodo neinfektsiinykh zakhvoriuvan dlia dosiahnennia hlobalnykh tsilei staloho rozvytku [On the approval of the National Action Plan on Noncommunicable Diseases to Achieve Global Sustainable Development Goals]. Order dated 2018 Jul 28 No. 530-r [Internet]. 2018 [cited 2024 Jun 1]. Ukrainian. Available from: https://zakon.rada.gov.ua/laws/show/530-2018-р#Text
National repository of academic texts [Internet]. 2024 [cited 2024 Jun 1]. Available from: https://nrat.ukrintei.ua/searchdb/?_token=JsmsLfg1niuTYfbBd59MWi3bwtQokY11Mdhe2LnK&typeSearch2=okd&authorSearch=&specialnistSearch=15.00.01&temaSearch2=&textSearch=&dateFromSearch=2013-01-01&dateToSearch=2023-07-16®istrationNumberSearch=&sortOrder=registration _date&sortDir=desc&tab=big
Study for Pharmaceutical Care Model in Community Management of Elderly Patients with Coronary Heart Disease. ChiCTR1800019172 [Internet]. International Clinical Trials Registry Platform. 2018 [cited 2024 Jun 1]. Available from: https://trialsearch.who.int/Trial2.aspx?TrialID=ChiCTR1800019172
Cochrane Library [Internet]. Cochranelibrary.com. [cited 2024 Jun 01]. Available from: https://www.cochranelibrary.com/search
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
